"Sylvester Hollywood is a hub for Sylvester’s innovative cancer services, providing uniquely tailored treatments for the most rare and challenging cancers. Our subspecialized multidisciplinary team is led by Ney Alves, MD, an expert in oncology and hematology with a special interest in myeloma and lymphoma, who serves as the facility’s Medical Director. Sylvester Cancer Center at Hollywood provides World Class personalized care through our expert caregiver team and state of the art facility."

During the past decade, UM Sylvester Comprehensive Cancer Center at Hollywood conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Hollywood" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UM Sylvester Comprehensive Cancer Center at Hollywood" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "UM Sylvester Comprehensive Cancer Center at Hollywood" in a lesser frequency.

Most popular intervention types in "UM Sylvester Comprehensive Cancer Center at Hollywood" are "Drug" (12 trials), "Other" (12 trials), "Biological" (9 trials), "Procedure" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (8 trials), "Nivolumab" (6 trials), "Biospecimen Collection" (4 trials), "Computed Tomography" (4 trials) and "Clinical Observation" (3 trials). Other intervention names were less common.

The vast majority of trials in "UM Sylvester Comprehensive Cancer Center at Hollywood" are 15 trials for "All" genders.

Currently, there are NaN active trials in "UM Sylvester Comprehensive Cancer Center at Hollywood". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UM Sylvester Comprehensive Cancer Center at Hollywood, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UM Sylvester Comprehensive Cancer Center at Hollywood, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".